Stock CHINA KANGTAI CACTUS BIO-TECH INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News China Kangtai Cactus Bio-Tech Inc.

Equities

US16939W1018

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for China Kangtai Cactus Bio-Tech Inc.

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
China Kangtai Cactus Bio-Tech Inc. : China Kangtai Cactus Biotech Announces Delay In Filing of Audited Financial Statements
BU
China Kangtai Cactus Bio-Tech Inc. : China Kangtai Cactus Announces New Nutraceutical Product
BU
China Kangtai Cactus Bio-Tech Inc. : China Kangtai Cactus Announces Launch of New, Improved Cactus Beverage
BU
China Kangtai Cactus Bio-Tech Inc. : China Kangtai Cactus's New Technique Improves Taste of Cactus Cigarette
BU
China Kangtai Cactus Bio-Tech Inc. : China Kangtai Cactus Biotech Q3 Revenue Up 39% to $13.3M; Q3 Operating Income Up 72% to $5.38M; EPS $0.18; Net Income Up 42% to $4M. YTD Revenue Up 23% to $29.2M; Operating Income Up 71% to $11.26M
BU
CHINA KAN : China Kangtai Cactus to Enter German Tobacco Market
BU
CHINA KAN : China Kangtai Cactus Biotech Q2 Revenue Up 9% to $9.5M; Q2 Operating Income Up 68% to $3.85M; EPS $0.13; YTD Revenue Up 12% to $15.96M; Operating Income Up 69% to $5.88M
BU
CHINA KAN : China Kangtai Cactus Co-Develops New Cigarette for Russian Market
BU
CHINA KAN : China Kangtai Cactus Biotech Q1 Revenue Up 21% to $6.7M; Operating Income Up 72% to $2.0M
BU
CHINA KAN : China Kangtai Cactus Announces Consumer Launch of New Low Nicotine Cigarette
BU
CHINA KAN : China Kangtai Cactus Provides Further Clarification of Kodiak Financing
BU
CHINA KAN : China Kangtai Cactus Announces $1.5M Capital Investment From Kodiak Capital Group
BU
CHINA KAN : China Kangtai Cactus Biotech Expands Use of Cactus Raw Material Product
BU
CHINA KAN : China Kangtai Cactus CEO Responds to Allegation
BU
CHINA KAN : China Kangtai Cactus Biotech Full Year Revenue Up 36% to $36M; Net Income up Significantly to $11.8M; Q4 Revenue Up 44% to $12.3M; Net Income Up 959% to $3.6M
BU
CHINA KAN : China Kangtai Cactus Biotech To Announce 2010 Financial Results on March 31
BU
CHINA KAN : China Kangtai Cactus Signs Manufacturing Agreement with Shandong Tobacco Company
BU
CHINA KAN : China Kangtai Cactus Provides Shareholder Update and Q4 Guidance
BU
CHINA KAN : China Kangtai Cactus Announces Technology Agreement with Shandong Tobacco Company
BU
CHINA KAN : China Kangtai Cactus Bio-tech Inc. Conducts High-Level Business Negotiations with Taiwan Tong He Mai Bio-tech Inc.
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News China Kangtai Cactus Bio-Tech Inc.